Mitotic kinesin inhibitors

Details for Australian Patent Application No. 2005262373 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Olson, Christy M.; Bergman, Jeffrey M.; Li, Chunze; Coleman, Paul J.; Garbaccio, Robert M.; Tasber, Edward S.; Neilson, Lou Anne; Hartman, George D.; Fraley, Mark E.

Agent Spruson & Ferguson

Pub. Number AU-B-2005262373

PCT Pub. Number WO2006/007491

Priority 60/584,808 01.07.04 US; 60/600,901 12.08.04 US

Filing date 27 June 2005

Wipo publication date 19 January 2006

Acceptance publication date 17 March 2011

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/5383 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/007491 Priority application(s): WO2006/007491

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 March 2011 Application Accepted

  Published as AU-B-2005262373

14 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262376-Bumper impact-testing device

2005262371-Resorbable implant with lubricious coating